News Image

23andMe to Report Q2 FY2025 Financial Results

Provided By GlobeNewswire

Last update: Nov 7, 2024

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report financial results for the second quarter of fiscal year 2025 (FY2025) after the market closes on Tuesday, November 12, 2024. The Company will webcast a conference call at 4:30 p.m. Eastern Time on that date to discuss the quarter’s results and report on business progress.

Read more at globenewswire.com

23ANDME HOLDING CO -CLASS A

NASDAQ:ME (2/21/2025, 8:00:01 PM)

After market: 2.5 +0.08 (+3.31%)

2.42

-0.32 (-11.68%)



Find more stocks in the Stock Screener

Follow ChartMill for more